Lymph node removal in pancreatic cancer surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies whether removing extra lymph nodes during surgery for pancreatic cancer can help find if the cancer has spread. It is for patients whose tumor is considered removable or borderline removable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are suspected to have periampullary cancer (a type of cancer near the pancreas).
- Your tumor can be removed by surgery or is borderline removable according to standard guidelines.
- You are older than 18 years.
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at removing certain lymph nodes near the aorta while doing a standard Whipple operation for pancreatic head cancer. The goal is to see whether this approach can improve how well doctors manage the cancer spread.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
This study looks at people with borderline-resectable or locally advanced pancreatic cancer to see how treatment choices affect survival, quality of life, and whether tumors can be removed by surgery. It may help doctors better predict who can benefit from surgical approaches and what outcomes matter most to patients.
This trial compares two ways of doing a major pancreas-and-duodenum operation: laparoscopic (small incisions) versus open surgery (larger incision). It aims to see which approach works better for nonpancreatic periampullary adenocarcinoma when the goal is cure.
This trial is testing whether surgery can help people with a certain type of pancreatic cancer that is locally advanced but not yet spread. You may join if your cancer has shrunk or stayed stable after at least 4 months of chemotherapy and your medical team thinks surgery is possible.
This study follows patients who have pancreatic surgery where the surgeon also removes and repairs a nearby vein (portal or superior mesenteric vein) to remove the cancer completely. Researchers want to understand how well this approach works and what happens to patients after surgery.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.